Will Reed
1.9K posts

Will Reed
@willreed
gp @sparkcapital


In the AI era, the traditional biopharma industry is the underdog. Big tech and AI labs are building wet labs. China has overtaken Europe in molecules produced. But the tools available to the industry discuss science, not do it. The hard problem in AI for science is at the interface between the physical and digital worlds. We built an AI Scientist at that seam. It wires together the digital and physical worlds of R&D. Predictive models, data infrastructure, wet lab execution feed into a single loop that reasons, acts, and improves with every experiment. Our ambition: get molecules to the clinic twice as fast. Last fall I wrote about why biotech needs to be rebuilt for the AI era. Today I'm sharing the next chapter: what the AI Scientist is, a blueprint for how it works, and why even Richard Feynman couldn't hack it in a wet lab.

We’ve raised 75m in new funding from Sequoia and Spark Capital—partnering with @sonyatweetybird, @MikowaiA, and @YasminRazavi, all of whom are deeply supportive of our long-term mission. We’ve also brought on angels & advisors including @karpathy, @tszzl, and @_milankovac_. ----- Our early results with FDM-1 moved computer use from a data-constrained regime to a compute-constrained one; this latest round of funding unlocks several orders of magnitude of compute scaling for that work. With the FDM model series we have a path to scale agentic capabilities through video pretraining, and we expect to achieve superhuman performance on general computer tasks in the same way that current language models have superhuman performance on coding tasks. We’re also now able to invest in the blue-sky research necessary to our long term mission of building aligned general learners. To realize the civilizationally transformative impacts of AI, models must generalize far out of their training distributions, actively exploring and building skills in new environments. This capability represents a substantial shift from the current paradigm of model training. We believe that current alignment techniques are insufficient to predictably and safely steer a model with human-level learning capabilities, and so we’re doing work to study small versions of this problem in controlled environments to develop a science of alignment for general learners. We’re a team of 6 people in San Francisco. We’re hiring world-class researchers and engineers to help us achieve our mission. If that’s you, please get in touch.



Our developer suite just got a new addition: Mercury CLI.


We raised a Series B led by @sequoia at a $2 billion valuation and I’m excited to welcome @andrew__reed to our board. All our existing investors doubled down: @kleinerperkins, @IndexVentures, @khoslaventures, @firstround, @sparkcapital, @AbstractVC, and @terraincap.

@sytaylor Pretty sure no one has ever crossed these two off in the same week






The world has more promising discovered drug candidates than ever. The problem is developing them. We built Formation Bio to fix that, using AI to develop drugs faster and with a higher likelihood of success. Thank you @amyfeldman and @Forbes telling the story of our mission, and our vision for the future of pharma. forbes.com/sites/amyfeldm…

The world has more promising discovered drug candidates than ever. The problem is developing them. We built Formation Bio to fix that, using AI to develop drugs faster and with a higher likelihood of success. Thank you @amyfeldman and @Forbes telling the story of our mission, and our vision for the future of pharma. forbes.com/sites/amyfeldm…




